Matthew Killeen

Matthew Killeen

Director Técnico/Científico/I+D en RENOVACOR, INC. .
44 años
Health Technology
Consumer Services
Retail Trade

Perfil

Matthew Killeen is currently the Director at Sudden Cardiac Arrest Foundation, Advisor-Scientific Affairs at CREAGRI, Inc., and Chief Scientific Officer at Renovacor, Inc. He previously worked as the Head-Cardiovascular Research at BioMarin Pharmaceutical, Inc. and as a Principal at Eli Lilly & Co. Ltd. Killeen holds a doctorate degree from the University of Cambridge and an undergraduate degree from the University of Leeds.

Cargos activos de Matthew Killeen

EmpresasCargoInicio
RENOVACOR, INC. Director Técnico/Científico/I+D 01/09/2021
Corporate Officer/Principal 12/05/2011
Director/Miembro de la Junta -

Antiguos cargos conocidos de Matthew Killeen.

EmpresasCargoFin
BIOMARIN PHARMACEUTICAL INC. Director Técnico/Científico/I+D -
Corporate Officer/Principal -
Ver el detalle de la experiencia de Matthew Killeen.

Formación de Matthew Killeen.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

6

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas7

Health Technology

Consumer Services

Consumer Services

Health Technology

Retail Trade

Health Technology

Commercial Services